γ-Glutamyl transferase is associated with mortality outcomes independently of fatty liver

Clinical Chemistry

Volumn 61, Issue 9, 2015, Pages 1173-1181

  Sung, Ki Chul ^a   Ryu, Seungho ^a   Kim, Bum Soo ^a   Cheong, Eun Sun ^a   Park, Dong Il ^a   Kim, Byung Ik ^a   Kwon, Min Jung ^a   Wild, Sarah H ^b   Byrne, Christopher D ^c  

^a School of Medicine   (South Korea)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ARTICLE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; ECHOGRAPHY; ENZYME ACTIVITY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; AGED; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; MORTALITY; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84942546644     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.240424     Document Type: Article

References (25)

1. Sørensen HT, Moller-Petersen JF, Felding P, Andreasen C, Nielsen JO. Epidemiology of abnormal liver function tests in general practice in a defined population in Denmark. Dan Med Bull 1991;38:420-2.
2. Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol 2013;18:53-6.
3. Claessen H, Brenner H, Drath C, Arndt V. Gamma-glutamyltransferase and disability pension: A cohort study of construction workers in Germany. Hepatology 2010;51:482-90.
4. Du G, Song Z, Zhang Q. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: A meta-analysis of prospective cohort studies. Prev Med 2013;57:31-7.
5. Kengne AP, Czernichow S, Stamatakis E, Hamer M, Batty GD. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three Br health surveys. J Hepatol 2012;57:1083-9.
6. Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, Hofman A, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int 2014;34:296-304.
7. Kunutsor SK, Apekey TA, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: A systematic review and meta-analysis. Int J Epidemiol 2014;43:187-201.
8. Loomba R, Doycheva I, Bettencourt R, Cohen B, Wassel CL, Brenner D, Barrett-Connor E. Serum gammaglutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults. J Clin Exp Hepatol 2013;3:4-11.
9. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med 2010;48:147-57.
10. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
11. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
12. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33.
13. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hepatology 2010;52:1156-61.
14. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7.
15. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009;136:477-85 e11.
16. Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, Volzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009;50:1403-11.
17. Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemela OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008;88:1097-103.
18. Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009;49:802-8.
19. Lee DH, Blomhoff R, Jacobs DR, Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9.
20. Lee DH, Jacobs DR, Jr. Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants? Free Radic Res 2009;43:533-7.
21. Zhang H, Forman HJ. Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 2009;41:509-15.
22. Kunutsor SK, Apekey TA, Van Hemelrijck M, Calori G, Perseghin G. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta-analysis. Int J Cancer 2015;136:1162-70.
23. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: Analysis of the british women's heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol 2007;27:2729-35.
24. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: Analysis of data from two prospective cohort studies. BMJ 2010;340:c1240.
25. Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. From NAFLD in clinical practice to answers from guidelines. J Hepatol 2013;59:859-71.